192 related articles for article (PubMed ID: 1909636)
1. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
[TBL] [Abstract][Full Text] [Related]
3. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
4. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
6. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease.
Weigand K; Zaugg PY; Frei A; Zimmermann A
Hepatology; 1984; 4(5):835-8. PubMed ID: 6479852
[TBL] [Abstract][Full Text] [Related]
8. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.
Hayasaka A; Schuppan D; Ohnishi K; Okuda K; Hahn EG
J Hepatol; 1990 Jan; 10(1):17-22. PubMed ID: 2307825
[TBL] [Abstract][Full Text] [Related]
10. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
11. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
Nyberg A; Lindqvist U; Engström-Laurent A
J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
[TBL] [Abstract][Full Text] [Related]
12. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
[TBL] [Abstract][Full Text] [Related]
13. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
14. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
[TBL] [Abstract][Full Text] [Related]
15. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis.
Annoni G; Cargnel A; Colombo M; Hahn EG
J Hepatol; 1986; 2(3):379-88. PubMed ID: 3722792
[TBL] [Abstract][Full Text] [Related]
16. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
17. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
19. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
20. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]